Omeros Corporation: Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment

AI Briefing

• – Omeros Corporation to present on TA-TMA treatment advances at EBMT 2026.
• – Company will highlight ongoing clinical trials and new data supporting the potential of TA-TMA for treating certain blood cancers.
• – Event will take place on March 22 at the EBMT Annual Meeting.